Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,374 | 3,537 | 2,920 | 3,081 | 3,182 |
| Other current assets | 284 | 456 | 125 | 184 | 408 |
| TOTAL | $20,658 | $3,993 | $3,045 | $3,265 | $3,590 |
| Non-Current Assets | |||||
| PPE Net | 21 | 22 | 23 | 33 | 43 |
| Other Non-Current Assets | 104 | 124 | 144 | 164 | 183 |
| TOTAL | $125 | $146 | $167 | $197 | $226 |
| Total Assets | $20,783 | $4,139 | $3,212 | $3,462 | $3,816 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 387 | 377 | 65 | 119 | 227 |
| Accrued Expenses | 360 | 60 | 224 | 80 | 269 |
| Other current liabilities | N/A | 383 | N/A | 63 | N/A |
| TOTAL | $750 | $828 | $305 | $286 | $529 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3 | 8 | 16 | 24 | 33 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $750 | $828 | $305 | $286 | $529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7 | 2 | 2 | 2 | 2 |
| Common Shares | 10 | 3 | 3 | 15 | 12 |
| Retained earnings | -70,264 | -69,065 | -67,994 | -67,154 | -66,227 |
| TOTAL | $20,033 | $3,311 | $2,907 | $3,176 | $3,287 |
| Total Liabilities And Equity | $20,783 | $4,139 | $3,212 | $3,462 | $3,816 |